Home › Stocks › GDTC › Changes

Who bought & sold GDTC (Q3 2026)

Funds holding (Q3 2026)6
New positions4
Added1
Reduced0
Exited1

As of Q3 2026, 6 institutional funds reported holding GDTC (CYTOMED THERAPEUTICS LIMITED): 4 opened new positions, 1 added, 0 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (4)

Fund Shares Value Weight
SUSQUEHANNA INTERNATIONAL GROUP, LLP New 31.40K $26.47K —
StoneX Group Inc. New 26.96K $24.45K 0.0
HRT FINANCIAL LP New 25.64K $21.00K —
TWO SIGMA SECURITIES, LLC New 12.98K $10.94K 0.0

Added to positions (1)

Fund Shares Value Weight Change
UBS Group AG 38.90K $32.79K — +34.07K sh (+705.2%)

Reduced positions (0)

No trims this quarter.

Exited positions (1)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Axiom Investment Management LLC Exited 7.03K $7.24K 0.0